Your browser doesn't support javascript.
loading
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido, Felipe; Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto; Arrazubi, Virginia; Hernandez, Raquel; Cano, Juana M; Custodio, Ana; Pericay Pijaume, Carles; Aguado, Gema; Martínez Lago, Nieves; Sánchez Cánovas, Manuel; Cacho Lavin, Diego; Visa, Laura; Martinez-Torron, Alba; Arias-Martinez, Aranzazu; López, Flora; Limón, M Luisa; Vidal Tocino, Rosario; Fernández Montes, Ana; Alsina, Maria; Pimentel, Paola; Reguera, Pablo; Martín Carnicero, Alfonso; Ramchandani, Avinash; Granja, Mónica; Azkarate, Aitor; Martín Richard, Marta; Serra, Olbia; Hernández Pérez, Carolina; Hurtado, Alicia; Gil-Negrete, Aitziber; Sauri, Tamara; Morales Del Burgo, Patricia; Gallego, Javier.
Afiliación
  • Alvarez-Manceñido F; Pharmacy Department, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain. felipealvarezm@yahoo.es.
  • Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
  • Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.
  • Arrazubi V; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain.
  • Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
  • Pericay Pijaume C; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain.
  • Aguado G; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Sánchez Cánovas M; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain.
  • Martinez-Torron A; Pharmacy Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Arias-Martinez A; Pharmacy Department, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain.
  • López F; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
  • Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain.
  • Alsina M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Pimentel P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain.
  • Reguera P; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Martín Carnicero A; Medical Oncology Department, Hospital San Pedro, Logroño, Spain.
  • Ramchandani A; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Azkarate A; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain.
  • Martín Richard M; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.
  • Serra O; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain.
  • Hernández Pérez C; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain.
  • Hurtado A; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Gil-Negrete A; Medical Oncology Department, Hospital Universitario Donostia, San Sebastián, Spain.
  • Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Morales Del Burgo P; Pathology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain.
Gastric Cancer ; 24(4): 926-936, 2021 07.
Article en En | MEDLINE | ID: mdl-33651195
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: España